An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Clinical trial NCT01136967 · COMPLETED
Trial details
- NCT number
- NCT01136967
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-04-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.